Prevalence of Preoperative Dehydration in Major Elective Urologic Surgery and Its Impact on Postoperative Outcome

Overview

The primary objective of this study is to measure the prevalence of preoperative dehydration in elective major abdominal urologic surgery when we apply our daily standard operation procedures. Secondary objectives are to assess the impact of preoperative dehydration on postoperative outcome. The hypothesis is that preoperative dehydration leads to more postoperative complications.

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Prospective
  • Study Primary Completion Date: March 16, 2020

Detailed Description

The information about the impact of preoperative dehydration on postoperative outcome is conflicting. One of the reported difficulties of the studies in this field is to get adequate power for statistical significance. The incidence of preoperative dehydration in different surgical populations has been reported in about one third of patients. The prevalence in the urologic population is not known. This is a monocentric observational study with no study intervention. The goal is to consecutively include all patients undergoing major urologic surgery during 365 days who meet the inclusion criteria to assess the prevalence of preoperative dehydration in elective major abdominal urologic surgery when the standard operation procedures of the University Hospital Bern are applied.

Clinical Trial Outcome Measures

Primary Measures

  • Prevalence of Dehydration at Induction of Anesthesia
    • Time Frame: Time point 0: time (estimated between 7am and 4pm on day of surgery) at Induction of Anesthesia for Major Urologic Surgery
    • Number of dehydrated patients judged by urine specific gravity, osmolality, creatinine, color.

Secondary Measures

  • Postoperative Nausea and Vomiting (PONV)
    • Time Frame: 6 hours, 24 hours and 48 hours postoperatively
    • Number of patients with postoperative nausea and/or vomiting at 6, 24 and 48 hours postoperatively.
  • Gastrointestinal function (flatus/defecation) postoperatively
    • Time Frame: 24 hours and 48 hours postoperatively
    • Time of first flatus or defecation
  • Renal function postoperatively
    • Time Frame: 6 hours, 24 hours and 48 hours postoperatively
    • Creatinine 6, 24 and 48 hours postoperatively.
  • Fluid balance
    • Time Frame: within 24 hours postoperatively
    • Judged by administered and lost fluids intraoperatively and by weight balance on postoperative day (POD) 1.
  • Complications within hospitalization
    • Time Frame: within hospital stay, expected to be within 2 weeks postoperatively
    • Number of complications according to a prospective list
  • Quality of recovery
    • Time Frame: 24 hours postoperatively
    • Changes in Quality of Recovery using the validated 15 items quality of recovery (QoR-15) score : QoR is a patient reported outcome short questionnaire that measure the quality of recovery after surgery and anaesthesia. It incorporates 5 dimensions of health (patient support, comfort, emotions, physical independence, pain). This is a shortened validated version of the QoR 40 including 15 items. QoR-15, with a score range from 0 to 150 (0 worst possible, 150 best possible), is easy to perform. Recently a meta-analysis showed that QoR 15 fulfils requirements for outcome measurement instruments.

Participating in This Clinical Trial

Inclusion Criteria

  • >18 years old – Major elective urologic surgery i. Prostate surgery ii. Bladder surgery iii. Kidney surgery iv. Various laparotomies / laparoscopies (e.g. retroperitoneal lymphadenectomy) – Standard procedure planned – Standard perioperative management planned – Informed consent Exclusion Criteria:

  • Preoperative iv-fluids – Pregnancy (which is a contraindication to this type of surgery per se) – Inability to give informed consent (e.g. severe psychiatric disorder, dementia) – Inability to complete the Quality of Recovery (QoR) questionnaire – Enrolment of the investigator, his/her family members, employees and other dependent persons

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Insel Gruppe AG, University Hospital Bern
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Official(s)
    • Lukas M Löffel, M.D., Principal Investigator, Inselspital University Hospital Bern

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.